美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

阿庫拉製藥

0.0100

+0.00951900.00%

成交量：120.00

成交額：1.20

市值：66.50萬

市盈率：-0.50

高：0.0100

開：0.0100

低：0.0100

收：0.0005

52周最高：0.0200

52周最低：0.0001

股本：6,649.93萬

流通股本：999.03萬

量比：2.22

換手率：0.00%

股息：- -

股息率：- -

每股收益(TTM):-0.0200

每股收益(LYR):-0.0200

淨資產收益率：15.24%

總資產收益率：-58.46%

市淨率：3.74

市盈率(LYR):-0.50

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

阿庫拉製藥

交易所：

EXPERT

成立時間：

1935

員工人數：

- -

公司地址：

616 N. North Court,Suite 120,Palatine,Illinois,United States

官網：

http://www.acurapharm.com

郵編：

60067

電話：

傳真：

847 705 5399

簡介：

Acura Pharmaceuticals, Inc.是一家紐約公司，其子公司是一家專業製藥公司，從事產品和技術的研究、開發和商業化，旨在解決藥物濫用和誤用。該公司已經研發了兩項專利技術。公司的反感技術（Aversion Technology）是將惰性成分的混合物用於藥片和膠囊，旨在解決一些常見的類鴉片藥物的濫用。 Pfizer控股公司的鹽酸羥考酮片是首個被批准銷售的利用反感技術製成的藥品，是公司與 Pfizer的子公司簽訂協議后合作開發的。該公司還開發了結合非活性成分的阻礙技術,防止從藥片中提取偽麻黃鹼，防止偽麻黃鹼直接轉換成冰毒。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/ACUR/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"ACUR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACUR\",,,,,undefined,":{"symbol":"ACUR","market":"US","secType":"STK","nameCN":"阿庫拉製藥","latestPrice":0.01,"timestamp":1773933572459,"preClose":0.0005,"halted":0,"volume":120,"delay":15,"changeRate":19,"floatShares":9990324,"shares":66499283,"eps":-0.02,"marketStatus":"交易中","change":0.0095,"latestTime":"03-19 11:19:32 EDT 延時","open":0.01,"high":0.01,"low":0.01,"amount":1.2,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.02,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1773950400000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"EXPERT","adjPreClose":0.0005,"volumeRatio":2.215906},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACUR\",,,,,undefined,":{"symbol":"ACUR","floatShares":9990324,"roa":"-58.46%","roe":"15.24%","lyrEps":-0.02,"volumeRatio":2.215906,"shares":66499283,"dividePrice":0,"high":0.01,"amplitude":0,"preClose":0.0005,"low":0.01,"week52Low":0.0001,"pbRate":"3.74","psRate":"0.43","week52High":0.02,"institutionHeld":0,"latestPrice":0.01,"eps":-0.02,"divideRate":0,"volume":120,"delay":15,"ttmEps":-0.02,"open":0.01,"prevYearClose":0.0005,"prevWeekClose":0.0005,"prevMonthClose":0.0005,"prevQuarterClose":0.0005,"fiveDayClose":0.0005,"twentyDayClose":0.0005,"sixtyDayClose":0.0005},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ACUR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2021-05-17","symbol":"ACUR","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1621224000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2021-03-31","symbol":"ACUR","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1617163200000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2020-11-16","symbol":"ACUR","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1605502800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2020-06-29","symbol":"ACUR","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1593403200000,"reportTimeType":"post","actualEps":null},{"date":"2020-06-15","symbol":"ACUR","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1592251200000,"name":null,"time":"盤後","dateTimestamp":1592193600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ACUR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ACUR\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":29262,"yearFounded":1935,"address":"616 N. North Court,Suite 120,Palatine,Illinois,United States","zipCode":"60067","officePhone":"847 705 7709","officeFax":"847 705 5399"},"stockCompanyDetail":{"websiteUrl":"http://www.acurapharm.com","stockEarnings":[{"period":"1week","weight":-0.1892},{"period":"1month","weight":0},{"period":"3month","weight":0.4925},{"period":"6month","weight":0.6575},{"period":"1year","weight":0.0345},{"period":"ytd","weight":1.611}],"description":"Acura Pharmaceuticals, Inc.是一家紐約公司，其子公司是一家專業製藥公司，從事產品和技術的研究、開發和商業化，旨在解決藥物濫用和誤用。該公司已經研發了兩項專利技術。公司的反感技術 （Aversion Technology） 是將惰性成分的混合物用於藥片和膠囊，旨在解決一些常見的類鴉片藥物的濫用。 Pfizer控股公司的鹽酸羥考酮片是首個被批准銷售的利用反感技術製成的藥品，是公司與 Pfizer的子公司簽訂協議后合作開發的。該公司還開發了結合非活性成分的阻礙技術,防止從藥片中提取偽麻黃鹼，防止偽麻黃鹼直接轉換成冰毒。","exchange":"EXPERT","name":"阿庫拉製藥","nameEN":"Acura Pharmaceuticals, Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"ACUR\",market:\"US\",,,undefined,":null}}